lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate

C52H57F2LiN10O7S2 — CID 161108961

IUPAClithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate
SMILESO.O=C(O)c1ccc2c(c1)CCN2c1ccc(F)cc1.O=C(c1ccc2c(c1)CCN2c1ccc(F)cc1)N1CC(N2CCN(C(=O)c3nccs3)CC2)C1.O=C(c1nccs1)N1CCN(C2CNC2)CC1.[Li+].[OH-]
InChIInChI=1S/C26H26FN5O2S.C15H12FNO2.C11H16N4OS.Li.2H2O/c27-20-2-4-21(5-3-20)32-9-7-18-15-19(1-6-23(18)32)25(33)31-16-22(17-31)29-10-12-30(13-11-29)26(34)24-28-8-14-35-24;16-12-2-4-13(5-3-12)17-8-7-10-9-11(15(18)19)1-6-14(10)17;16-11(10-13-1-6-17-10)15-4-2-14(3-5-15)9-7-12-8-9;;;/h1-6,8,14-15,22H,7,9-13,16-17H2;1-6,9H,7-8H2,(H,18,19);1,6,9,12H,2-5,7-8H2;;2*1H2/q;;;+1;;/p-1
InChIKeyZVPOHPQJFGMPPI-UHFFFAOYSA-M
MW1043.16 g/mol
LogP2.35
Rot. Bonds8

About lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate

lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate (PubChem CID 161108961) has the molecular formula C52H57F2LiN10O7S2 and a molecular weight of 1043.16 g/mol. Its IUPAC name is lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate.

Molecular Properties

Compound Namelithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate
PubChem CID161108961
Molecular FormulaC52H57F2LiN10O7S2
Molecular Weight1043.16 g/mol
Exact Mass1042.40
IUPAC Namelithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate
SMILESO.O=C(O)c1ccc2c(c1)CCN2c1ccc(F)cc1.O=C(c1ccc2c(c1)CCN2c1ccc(F)cc1)N1CC(N2CCN(C(=O)c3nccs3)CC2)C1.O=C(c1nccs1)N1CCN(C2CNC2)CC1.[Li+].[OH-]
InChIInChI=1S/C26H26FN5O2S.C15H12FNO2.C11H16N4OS.Li.2H2O/c27-20-2-4-21(5-3-20)32-9-7-18-15-19(1-6-23(18)32)25(33)31-16-22(17-31)29-10-12-30(13-11-29)26(34)24-28-8-14-35-24;16-12-2-4-13(5-3-12)17-8-7-10-9-11(15(18)19)1-6-14(10)17;16-11(10-13-1-6-17-10)15-4-2-14(3-5-15)9-7-12-8-9;;;/h1-6,8,14-15,22H,7,9-13,16-17H2;1-6,9H,7-8H2,(H,18,19);1,6,9,12H,2-5,7-8H2;;2*1H2/q;;;+1;;/p-1
InChIKeyZVPOHPQJFGMPPI-UHFFFAOYSA-M
XLogP2.35
TPSA210.50 Ų
H-Bond Donors2
H-Bond Acceptors14
Rotatable Bonds8
Heavy Atoms74
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001043.16
LogP ≤ 52.35
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1014

Analyze lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate?
The IUPAC name of lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate (CID 161108961) is lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate.
What is the SMILES notation for lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate?
The canonical SMILES for lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate is O.O=C(O)c1ccc2c(c1)CCN2c1ccc(F)cc1.O=C(c1ccc2c(c1)CCN2c1ccc(F)cc1)N1CC(N2CCN(C(=O)c3nccs3)CC2)C1.O=C(c1nccs1)N1CCN(C2CNC2)CC1.[Li+].[OH-].
What is the InChIKey of lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate?
The InChIKey is ZVPOHPQJFGMPPI-UHFFFAOYSA-M. The full InChI is InChI=1S/C26H26FN5O2S.C15H12FNO2.C11H16N4OS.Li.2H2O/c27-20-2-4-21(5-3-20)32-9-7-18-15-19(1-6-23(18)32)25(33)31-16-22(17-31)29-10-12-30(13-11-29)26(34)24-28-8-14-35-24;16-12-2-4-13(5-3-12)17-8-7-10-9-11(15(18)19)1-6-14(10)17;16-11(10-13-1-6-17-10)15-4-2-14(3-5-15)9-7-12-8-9;;;/h1-6,8,14-15,22H,7,9-13,16-17H2;1-6,9H,7-8H2,(H,18,19);1,6,9,12H,2-5,7-8H2;;2*1H2/q;;;+1;;/p-1.
What are the key properties of lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate?
lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate has a molecular weight of 1043.16 g/mol, XLogP of 2.35, 8 rotatable bonds, 2 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for lithium;[4-(azetidin-3-yl)piperazin-1-yl]-(1,3-thiazol-2-yl)methanone;1-(4-fluorophenyl)-2,3-dihydroindole-5-carboxylic acid;[1-(4-fluorophenyl)-2,3-dihydroindol-5-yl]-[3-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone;hydroxide;hydrate is sourced from PubChem (CID 161108961), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).